机构追踪 美股市场个股详情 HIMS Hims & Hers Health 添加自选 55.210 +3.250+6.25% 收盘价 05/12 16:00 (美东) 55.330 +0.120+0.22% 盘后20:01 (美东) 123.58亿总市值81.19市盈率TTM 58.600最高价54.200最低价5927.39万股成交量56.090今开51.960昨收33.26亿成交额30.76%换手率104.17市盈率(静)2.24亿总股本...
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization...
Hims & Hers Health, Inc. price and volume Combination chart with 2 data series. Chart represents Hims & Hers Health, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and symbol volume.. Feb 2025Dec...
What is Hims & Hers Health’s stock symbol? The ticker symbol for Hims & Hers Health is HIMS. What is the current stock price of Hims & Hers Health? As of 06-May-2025 the stock price of Hims & Hers Health is $49.47. What is the current market cap of Hims & Hers Health? The ...
Latest On Hims & Hers Health Inc ALL CNBCINVESTING CLUBPRO Stocks making the biggest moves after hours: Palantir, Ford, Mattel and more9 Hours AgoCNBC.com Hims & Hers gives weak outlook but says more collaborations are coming9 Hours AgoCNBC.com Here's why we're not buyers in Monday's ...
Check the Hims & Hers Health, Inc. stock price today on the NYSE stock exchange and access historical HIMS stock price chart. Get the latest Hims & Hers Health, Inc. stock information.
In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $43.57, changing hands for $45.09/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua...
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? 5 hours ago•Zacks Markets HIMS Factor-Based Stock Analysis 7 hours ago•Validea Stocks Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
智通财经APP获悉,在美国平价医疗保健公司Hims & Hers Health(HIMS.US)下周公布2024 年第四季度业绩之前,摩根士丹利周二将其评级从“增持”下调至“持平”,理由是该公司股票近期的强劲上涨。 自去年5月以来,总部位于加州旧金山的HIMS股价已攀升超过200%,当时该公司以大幅折扣推出了诺和诺德(NVO.US)广受欢迎的减肥疗法...
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.